Morning Briefing
Summaries of health policy coverage from major news organizations
Amgen To Pay $762 Million Fine For Improper Drug Marketing
Company's sales representatives promoted the drug Aranesp for unapproved uses.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.